Zhou, Chengzhi

Sintilimab Plus Platinum and Gemcitabine as First-Line Treatment for Advanced or Metastatic Squamous NSCLC: Results From a Randomized, Double-Blind, Phase 3 Trial (ORIENT-12)

Zhou, C., Wu, L., Fan, Y., Wang, Z., Liu, L., Chen, G., Zhang, L., Huang, D., Cang, S., Yang, Z., et al. (2021) · Journal of Thoracic Oncology

Cancer Immunotherapy and BiomarkersLung Cancer Treatments and Mutations

Cited by 322

Ivonescimab versus pembrolizumab for PD-L1-positive non-small cell lung cancer (HARMONi-2): a randomised, double-blind, phase 3 study in China

Xiong, A., Wang, L., Chen, J., Wu, L., Liu, B., Yao, J., Zhong, H., Li, J., Cheng, Y., Sun, Y., et al. (2025) · The Lancet

Cancer Immunotherapy and BiomarkersLung Cancer Treatments and Mutations

Cited by 173

The role of carbonate in sulfamethoxazole degradation by peroxymonosulfate without catalyst and the generation of carbonate racial

Sun, Y., Xie, H., Zhou, C., Wu, Y., Pu, M., & Niu, J. (2020) · Journal of Hazardous Materials

Advanced oxidation water treatmentWater Treatment and Disinfection

Cited by 108

Bicarbonate enhancing electrochemical degradation of antiviral drug lamivudine in aqueous solution

Wang, Y., Zhou, C., Chen, J., Fu, Z., & Niu, J. (2019) · Journal of Electroanalytical Chemistry

Advanced oxidation water treatmentEnvironmental remediation with nanomaterials

Cited by 27